Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction

OnabotulinumtoxinA (BoNT-A) was first used to treat neurogenic lower urinary tract dysfunction (LUTD) 30 years ago. Recently, application of BoNT-A in LUTD have become more common since the approval of intravesical BoNT-A injection for patients with both overactive bladders (OAB) and neurogenic detr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhang, Jia-Fong, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071213/
https://www.ncbi.nlm.nih.gov/pubmed/29949878
http://dx.doi.org/10.3390/toxins10070260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071213/
https://www.ncbi.nlm.nih.gov/pubmed/29949878
http://dx.doi.org/10.3390/toxins10070260

Ejemplares similares